Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.92 | €11.05 | 181.847% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €11.10 | €21.00 | 89.222% |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.67 | - | - |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.66 | €3.00 | 80.723% |
| Savara Inc. | 1 | 0 | 0 | 0 | €4.62 | €8.00 | 73.160% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €122.45 | €130.00 | 6.166% |
| Sanofi S.A. ADR | 11 | 0 | 0 | 0 | €45.80 | - | - |
| Sanofi S.A. | 5 | 0 | 1 | 0 | €94.47 | €99.50 | 5.324% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.92 | €13.77 | 1403.603% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.60 | €45.98 | 29.157% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €151.00 | €184.76 | 22.358% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 1 | €903.60 | €957.22 | 5.934% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.51 | €9.21 | 1723.168% |
| PTC Therapeutics Inc. | 13 | 5 | 2 | 0 | €28.20 | €41.81 | 48.277% |
| ProQR Therapeutics N.V. | 8 | 1 | 3 | 1 | €1.83 | €3.03 | 65.905% |
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| Poxel S.A. | 1 | 0 | 0 | 0 | €0.62 | €0.70 | 12.179% |
| Phibro Animal Health Corp. A | 4 | 2 | 0 | 1 | €15.80 | €12.06 | -23.646% |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.080 | - | - |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.01 | €41.10 | 58.028% |
| Personalis Inc | 7 | 0 | 2 | 0 | €1.50 | €3.25 | 117.275% |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €28.50 | €35.99 | 26.264% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.00 | €47.53 | 76.030% |
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €119.50 | €130.44 | 9.153% |